Journal of International Oncology››2016,Vol. 43››Issue (8): 578-583.doi:10.3760/cma.j.issn.1673-422X.2016.08.005
Previous ArticlesNext Articles
Wei Hualin, Zhou Ping, Guo Xiaopei, Liu Jianhui, Xia Tingyi, Ren Gang, Wang Yong.
Online:
2016-08-08Published:
2016-07-05Contact:
Zhou Ping, Email: zhouping4946@163.com E-mail:zhouping4946@163.comWei Hualin, Zhou Ping, Guo Xiaopei, Liu Jianhui, Xia Tingyi, Ren Gang, Wang Yong.. Gastroduodenal complications after tomotherapy in patients with pancreatic cancer: endoscopic findings and risk factors[J]. Journal of International Oncology, 2016, 43(8): 578-583.
[1] Kelly P, Das P, Beddar S, et al. Duodenal toxicity after fractionated chemoradiation for unresectable pancreatic cancer[J]. Int J Radiat Oncol Biol Phys, 2013, 85(3): e143-e149. DOI: 10.1016/j.ijrobp.2012.09.035. [2] Li D, Xie K, Wolff R, et al. Pancreatic cancer[J]. Lancet, 2004, 363(9414): 1049-1057. [3] Ikeda M, Ioka T, Ito Y, et al. A multicenter phase Ⅱ trial of S-1 with concurrent radiation therapy for locally advanced pancreatic cancer[J]. Int J Radiat Oncol Biol Phys, 2013, 85(1): 163-169. DOI: 10.1016/j.ijrobp.2012.03.059. [4] Hudson E, Hurt C, Mort D, et al. Induction chemotherapy followed by chemoradiation in locally advanced pancreatic cancer: an effective and welltolerated treatment[J]. Clin Oncol (R Coll Radiol), 2010, 22(1): 27-35. DOI: 10.1016/j.clon.2009.09.024. [5] Murphy JD, ChristmanSkieller C, Kim J, et al. A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer[J]. Int J Radiat Oncol Biol Phys, 2010, 78(5): 1420-1426. DOI: 10.1016/j.ijrobp.2009.09.075. [6] Chon YE, Seong J, Kim BK, et al. Gastroduodenal complications after concurrent chemoradiation therapy in patients with hepatocellular carcinoma: endoscopic findings and risk factors[J]. Int J Radiat Oncol Biol Phys, 2011, 81(5): 1343-1351. DOI: 10.1016/j.ijrobp.2010.07.1986 . [7] Yeomans ND, Naesdal J. Systematic review: ulcer definition in NSAID ulcer prevention trials[J]. Aliment Pharmacol Ther, 2008, 27(6): 465-472. DOI: 10.1111/j.13652036.2008.03610.x. [8] Takatori K, Terashima K, Yoshida R, et al. Upper gastrointestinal complications associated with gemcitabine-concurrent proton radiotherapy for inoperable pancreatic cancer[J]. J Gastroenterol, 2014, 49(6): 1074-1080. DOI: 10.1007/s00535-013-0857-3. [9] 万芝清, 陈晓, 周平, 等. 小鼠放射性十二指肠炎模型的建立[J]. 世界华人消化杂志, 2013, 21(23): 22672274. [10] Indaram AV, Visvalingam V, Locke M, et al. Mucosal cytokine production in radiationinduced proctosigmoiditis compared with inflammatory bowel disease[J]. Am J Gastroenterol, 2000, 95(5): 12211225. DOI: 10.1111/j.15720241.2000.02013.x. [11] Bae SH, Kim MS, Cho CK, et al. Predictor of severe gastroduodenal toxicity after stereotactic body radiotherapy for abdominopelvic malignancies[J]. Int J Radiat Oncol Biol Phys, 2012, 84(4): e469e474. DOI: 10.1016/j.ijrobp.2012.06.005. [12] Papatheodoridis GV, Sougioultzis S, Archimandritis AJ. Effects of helicobacter pylori and nonsteroidal antiinflammatory drugs on peptic ulcer disease: a systematic review[J]. Clin Gastroenterol Hepatol, 2006, 4(2): 130142. DOI: 10.1016/j.cgh.2005.10.006. [13] Baker DG, Krochak RJ. The response of the microvascular system to radiation: a review[J]. Cancer Invest, 1989, 7(3): 287294. [14] Lee KJ, Kim HM, Jung JW, et al. Gastrointestinal hemorrhage after concurrent chemoradiotherapy in locally advanced pancreatic cancer[J]. Gut Liver, 2013, 7(1): 106-111. DOI: 10.5009/gnl.2013.7.1.106. |
[1] | Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei.Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma: a real-world clinical study[J]. Journal of International Oncology, 2024, 51(6): 326-331. |
[2] | Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337. |
[3] | Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381. |
[4] | Qian Xiaotao, Shi Ziyi, Hu Ge.A real-world clinical study of immunocheckpoint inhibitor maintenance therapy after radical radiotherapy and chemotherapy in stage Ⅲ-ⅣA esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2024, 51(3): 151-156. |
[5] | Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing.Progress of radiotherapy in oligometastatic non-small cell lung cancer[J]. Journal of International Oncology, 2024, 51(3): 170-174. |
[6] | Gao Xinyu, Li Zhenjiang, Sun Hongfu, Han Dan, Zhao Qian, Liu Chengxin, Huang Wei.Clinical application of MR-guided radiotherapy based on MR-linac in esophageal cancer patients[J]. Journal of International Oncology, 2024, 51(1): 37-42. |
[7] | Cui Tenglu, Lyu lu, Sun Pengfei.Application of radiotherapy combined with immunotherapy in the treatment of head and neck squamous cell carcinoma[J]. Journal of International Oncology, 2023, 50(9): 548-552. |
[8] | Li Qingshan, Xie Xin, Zhang Nan, Liu Shuai.Research progress on the application of combining radiotherapy and systemic therapy in breast cancer[J]. Journal of International Oncology, 2023, 50(6): 362-367. |
[9] | Lyu Lu, Sun Pengfei.Gut flora and cervical cancer[J]. Journal of International Oncology, 2023, 50(6): 373-376. |
[10] | Radiation Oncology Treatment Physician Branch, Chinese Medical Doctor Association, Radiation Oncology Therapy Branch, Chinese Medical Association, Chinese Association of Radiation Therapy, China Anti-Cancer Association.Chinese experts' consensus on the application of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy (2023 version)[J]. Journal of International Oncology, 2023, 50(4): 193-201. |
[11] | Xu Meng, Jiang Wei, Zhu Haitao, Cao Xiongfeng.Research progress of cancer-associated fibroblasts in tumor radiotherapy resistance[J]. Journal of International Oncology, 2023, 50(4): 227-230. |
[12] | Shi Xaioqi, Wang Hongyan.Research progress on the interaction between gut microbiota and radiation enteritis[J]. Journal of International Oncology, 2023, 50(4): 244-247. |
[13] | Zhao Yongrui, Gao Ying, Chen Yidong, Xu Jiankun.Efficacy and safety of linear accelerator-based fractionated stereotactic radiotherapy for small volume brain metastases[J]. Journal of International Oncology, 2023, 50(3): 138-143. |
[14] | Huang Huayu, Gong Hongyun, Song Qibin.Influencing factors of pneumonitis in the period of thoracic radiotherapy combined with immunotherapy[J]. Journal of International Oncology, 2023, 50(2): 102-106. |
[15] | Cao Xiaohui, Yu Hong, Li Wanhu.Application of CT-based radiomics analysis in predicting and identifying of treatment-associated pneumonitis[J]. Journal of International Oncology, 2023, 50(2): 107-111. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||